BIOMARKER:

NRG1 overexpression

Entrez ID:

Related biomarkers:

‹

›

NRG1 overexpression NRG1 overexpression	Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma	NRG1 overexpression NRG1 overexpression	Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma	AV-203 Sensitive: C3 – Early Trials	AV-203 Sensitive: C3 – Early Trials
NRG1 overexpression NRG1 overexpression	Non Small Cell Lung Cancer NSCLC	NRG1 overexpression NRG1 overexpression	Non Small Cell Lung Cancer NSCLC	U3-1287 Sensitive: C3 – Early Trials	U3-1287 Sensitive: C3 – Early Trials
NRG1 overexpression NRG1 overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	NRG1 overexpression NRG1 overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	trastuzumab + pertuzumab Sensitive: C3 – Early Trials	trastuzumab + pertuzumab Sensitive: C3 – Early Trials
NRG1 overexpression NRG1 overexpression	Head and Neck Cancer Head and Neck Cancer	NRG1 overexpression NRG1 overexpression	Head and Neck Cancer Head and Neck Cancer	cetuximab Resistant: D – Preclinical	cetuximab Resistant: D – Preclinical